Currently, thyroid disease, which can lead to several serious health conditions such as osteoporosis, cardiovascular disease and hyperlipidemia, affects more than 14 million Americans.
On February 12, 2004, The Endocrine Society will host an audioconference to examine the issues regarding the newly defined thyroid stimulating hormone (TSH) range, the new approach for detecting and managing subclinical thyroid disease and the use of thyroid hormone replacement therapy.
The audioconference, which will be led by several recognized thyroid experts, will feature discussions on research from the October 2003 issue of the Journal of Clinical Endocrinology & Metabolism and the January 14th issue of Journal of the American Medical Association.
An opportunity for questions and comments will be provided at the end of the faculty presentations. Participation in the audioconference is free and open to the press. For additional information about the audioconference, please visit http://www.endo-society.org/education/cme_audio.cfm#thyroid
Audioconference: Current Issues in Thyroid Disease Management Implications from JAMA and JCEM Reports
Thursday, February 12, 2004
3:00 4:30 pm (EST)
Dr. David Sarne, M.D., Director of Endocrinology, University of Illinois College of Medicine, Chicago, IL
Dr. Carole Spencer, FACB, Ph.D., Professor of Medicine, University of Southern California, Los Angeles, CA
Dr. Kenneth Burman, M.D., Chief of Staff Endocrine Section, Washington Hospital Center, Kensington, M.D.
The Endocrine Society
Reporters who would like to register for the audioconference should send their name, email address, phone and fax numbers, mailing address and news organization to:
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.
Times of general calamity and confusion have ever been productive of the greatest minds. The purest ore is produced from the hottest furnace.
~ Charles Caleb Colton